Effectiveness trials: critical data to help understand how respiratory medicines really work?
Most of the information about the benefits, safety aspects, and cost effectiveness of pharmacological treatment in the respiratory field has been obtained from traditional efficacy studies, such as randomised controlled trials (RCT). The highly controlled environment of an RCT does not always reflec...
Main Authors: | Andreas Heddini, Josefin Sundh, Magnus Ekström, Christer Janson |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | European Clinical Respiratory Journal |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20018525.2019.1565804 |
Similar Items
-
Defining key design elements of registry-based randomised controlled trials: a scoping review
by: Bill Karanatsios, et al.
Published: (2020-06-01) -
Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)
by: Nicolle M. Gatto, et al.
Published: (2020-06-01) -
Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making
by: Katkade VB, et al.
Published: (2018-07-01) -
Informing real-world practice with real-world evidence: the value of PRECIS-2
by: Gila Neta, et al.
Published: (2018-05-01) -
Botanical drug clinical trial: Common issues and future options
by: Yu Sun, et al.
Published: (2021-01-01)